All data are based on the daily closing price as of December 5, 2024
n

NKMAX

182400.KQ
This stock is delisted

About

NKMAX CO., Ltd. manufactures and sells biological products in South Korea. The company offers anti-cancer immunotherapy treatment that activates the immune cells in body to kill the cancer cells; natural killer cell activity test for cancer patients; NK VUE Kit, an NK cell activity test that quantitatively measures IFN-gamma released from activated NK cells with small amount of blood; and NK365, a proprietary blend of vitamins, minerals, and agaricus mushroom extract for immune system. It also provides recombinant proteins and monoclonal antibodies; and NK PUPPY, a test that measures dog's immunity. The company was formerly known as ATGen Co and changed name to NKMAX CO., Ltd. in 2019. NKMAX CO., Ltd. was founded in 2002 and is headquartered in Seongnam-si, South Korea.
  • Symbol
    182400.KQ
  • Exchange
    KQ
  • Isin
    KR7182400002
  • Country
    South Korea
  • Sector
    N/A
  • Industry
    N/A
  • CEO
    Sang-Woo Park
  • Headquarter
    Seongnam-si
  • Web site
    https://www.nkmax.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top